We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$192M
AUM Growth
+$3.31M
Cap. Flow
+$10.5M
Cap. Flow %
5.46%
Top 10 Hldgs %
24.46%
Holding
454
New
344
Increased
40
Reduced
39
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2M
2
GS icon
Goldman Sachs
GS
+$1.47M
3
GSK icon
GSK
GSK
+$1.35M
4
JNJ icon
Johnson & Johnson
JNJ
+$608K
5
TOTL icon
State Street DoubleLine Total Return Tactical ETF
TOTL
+$360K

Top Sells

Rank Stock Value
1
LNCE
Snyders-Lance, Inc.
LNCE
+$3.92M
2
BF.B icon
Brown-Forman Class B
BF.B
+$2.98M
3
WBA
Walgreens Boots Alliance
WBA
+$1.52M
4
GIS icon
General Mills
GIS
+$227K
5
YUM icon
Yum! Brands
YUM
+$225K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.13%
2 Healthcare 18.47%
3 Financials 16.28%
4 Communication Services 8.75%
5 Miscellaneous 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$5.55M 2.9%
132,428
+1,436
+1% +$61.8K
VIG icon
2
Vanguard Dividend Appreciation ETF
VIG
$113B
$5.13M 2.68%
50,796
+3,114
+7% +$323K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.08T
$5.13M 2.68%
25,705
+609
+2% +$125K
BDX icon
4
Becton Dickinson
BDX
$51.6B
$4.97M 2.59%
23,492
-478
-2% -$105K
TMO icon
5
Thermo Fisher Scientific
TMO
$230B
$4.61M 2.41%
22,339
-50
-0.2% -$10.5K
UL icon
6
Unilever
UL
$140B
$4.61M 2.41%
73,739
-266
-0.4% -$16.2K
PG icon
7
Procter & Gamble
PG
$334B
$4.53M 2.37%
57,187
+981
+2% +$81.8K
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.24T
$4.36M 2.27%
84,040
+1,280
+2% +$71K
BUD icon
9
AB InBev
BUD
$158B
$4.02M 2.1%
36,540
+1,275
+4% +$141K
DHR icon
10
Danaher
DHR
$152B
$3.96M 2.06%
45,567
+1,298
+3% +$114K
DEO icon
11
Diageo
DEO
$51.7B
$3.92M 2.05%
28,950
-200
-0.7% -$27.8K
NKE icon
12
Nike
NKE
$58.7B
$3.58M 1.87%
53,868
-200
-0.4% -$13.2K
PM icon
13
Philip Morris
PM
$299B
$3.23M 1.69%
32,545
+382
+1% +$39.8K
MO icon
14
Altria Group
MO
$115B
$3.21M 1.68%
51,505
+500
+1% +$33.1K
SBUX icon
15
Starbucks
SBUX
$123B
$3.17M 1.66%
54,786
+711
+1% +$41.1K
T icon
16
AT&T
T
$178B
$3.12M 1.63%
115,945
+847
+0.7% +$23.6K
BTI icon
17
British American Tobacco
BTI
$121B
$3.1M 1.62%
53,756
-3,496
-6% -$220K
JNJ icon
18
Johnson & Johnson
JNJ
$646B
$3.07M 1.6%
23,973
+4,496
+23% +$608K
VZ icon
19
Verizon
VZ
$208B
$2.91M 1.52%
60,930
+1,759
+3% +$88.4K
MDLZ icon
20
Mondelez International
MDLZ
$79.6B
$2.88M 1.5%
69,075
+736
+1% +$32K
KHC icon
21
Kraft Heinz
KHC
$30.5B
$2.78M 1.45%
44,659
+3,984
+10% +$285K
TAP icon
22
Molson Coors Class B
TAP
$7.73B
$2.76M 1.44%
36,635
+1,297
+4% +$104K
TFC icon
23
Truist Financial
TFC
$61.6B
$2.7M 1.41%
51,931
+252
+0.5% +$13.6K
BAX icon
24
Baxter International
BAX
$13.5B
$2.7M 1.41%
41,500
-300
-0.7% -$20.3K
LUV icon
25
Southwest Airlines
LUV
$19.4B
$2.63M 1.37%
45,923
+1,500
+3% +$90.1K
1
2 3 4 5

Similar funds

GCM
Greenland Capital Management New York $812M AUM 45.54% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $811M AUM 19.06% 1-Year Est. Return
FA
Fagan Associates Troy, New York $813M AUM 37.92% 1-Year Est. Return
CFO
Cambient Family Office Ada, Michigan $813M AUM
REA
Renesas Electronics America San Jose, California $813M AUM
TLP
Tri Locum Partners New York $813M AUM 101.01% 1-Year Est. Return
BPIM
Brant Point Investment Management New York $813M AUM 60.46% 1-Year Est. Return

Kavar Capital Partners Group's Q1 2018 Portfolio in Review

As of Q1 2018, Kavar Capital Partners Group held 454 positions worth $192M, up 1.8% from $188M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Kavar Capital Partners Group deployed $10.5M of net new capital in Q1 2018, opening 344 new positions and adding to 40 existing holdings. Its largest new stake was Gilead Sciences: 25,100 shares worth $1.89M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $1.52M trimmed.

  • Kavar Capital Partners Group's largest Q1 2018 buy was Gilead Sciences: 25,100 shares worth $1.89M.
  • Kavar Capital Partners Group added most to GSK in Q1 2018, an estimated $1.35M increase.
  • Kavar Capital Partners Group's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $1.52M.
  • Kavar Capital Partners Group fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $3.92M.
  • Kavar Capital Partners Group's ten largest holdings make up 24% of its $192M portfolio in Q1 2018.
  • Kavar Capital Partners Group opened 344 new positions and closed 4 in Q1 2018.
  • Kavar Capital Partners Group's portfolio value rose 1.8% quarter-over-quarter to $192M.

Based on Kavar Capital Partners Group's 13F filing for Q1 2018, filed 16 May 2019.